Clinical Trials Browser

Phase 2 × Rectal Neoplasms × durvalumab × Clear all

NCT03102047 2022-04-20

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

NCT04293419 2021-06-21

DUREC

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04621370 2020-11-09

PRIME-RT

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms